ImmunoPrecise Antibodies Overview

  • Founded
  • 1989

Founded
  • Status
  • Public

  • Employees
  • 73

Employees
  • Stock Symbol
  • IPA

Stock Symbol
  • Investments
  • 8

  • Share Price
  • $3.79

  • (As of Thursday Closing)

ImmunoPrecise Antibodies General Information

Description

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United States of America.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
TSX
Primary Office
  • Vancouver Island Technology Park Unit
  • 3204-4464 Markham Street
  • Victoria, British Columbia V8Z 7X8
  • Canada
+1 (250) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunoPrecise Antibodies Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.79 $3.73 $3.55 - $16.07 $87.7M 23.5M 15.4K -$0.73

ImmunoPrecise Antibodies Financials Summary

In Thousands,
USD
TTM 31-Jan-2022 FY 2021 30-Apr-2021 FY 2020 30-Apr-2020 FY 2019 30-Apr-2019
EV 91,389 179,074 40,099 35,706
Revenue 15,162 13,667 10,522 8,291
EBITDA (8,897) (1,298) (375) (3,082)
Net Income (13,642) (5,600) (3,703) (5,780)
Total Assets 44,234 54,539 19,647 21,152
Total Debt 2,205 2,816 3,249 2,175
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ImmunoPrecise Antibodies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ImmunoPrecise Antibodies‘s full profile, request access.

Request a free trial

ImmunoPrecise Antibodies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The c
Biotechnology
Victoria, Canada
73 As of 2021
000.00
00000000 000.00

000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
0000000000000
Planegg, Germany
00 As of 0000
00000
000000000 00000

000000

ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proiden
0000000000000
Shirley, NY
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImmunoPrecise Antibodies Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MediGene Formerly VC-backed Planegg, Germany 00 00000 000000000 00000
00000000 000000000 Corporation Shirley, NY
000000000 Private Equity-Backed Piscataway, NJ 0000 00000 000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

ImmunoPrecise Antibodies Patents

ImmunoPrecise Antibodies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2947722-A1 Monoclonal antibodies for the identification and characterization of antiestrogens and selective estrogen receptor modulators Abandoned 04-Nov-2016 00000000000
CA-2947878-A1 Monoclonal antibodies and use thereof as a diagnostic tool for limb-girdle muscular dystrophy Pending 04-Nov-2016 000000000
CA-2964907-A1 Monoclonal antibodies and use thereof as a diagnostic tool for limb-girdle muscular dystrophy and genetically related disorders Pending 04-Nov-2016 000000000
CA-2965017-A1 Monoclonal antibodies for the identification and characterization of antiestrogens and selective estrogen receptor modulators Pending 04-Nov-2016 00000000000
CA-2940065-A1 Method for the rapid production of high affinity monoclonal anitibodies Pending 22-Aug-2016 C07K16/00
To view ImmunoPrecise Antibodies’s complete patent history, request access »

ImmunoPrecise Antibodies Executive Team (11)

Name Title Board Seat Contact Info
Jennifer Bath Ph.D Chief Executive Officer & Board Member
Lisa Helbling Chief Financial Officer, Finance
David Orton Chief Operating Officer
Ilse Roodink Ph.D Chief Scientific Officer
Timothy Miller Director, Business Development
You’re viewing 5 of 11 executive team members. Get the full list »

ImmunoPrecise Antibodies Board Members (6)

Name Representing Role Since
00000 000000000 ImmunoPrecise Antibodies Board Member 000 0000
0000 00000 Self Board Member 000 0000
00000 000 00 Self Chairman & Board Member 000 0000
00000000 0000 00.0 ImmunoPrecise Antibodies Chief Executive Officer & Board Member 000 0000
0000 00000000 Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

ImmunoPrecise Antibodies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImmunoPrecise Antibodies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ImmunoPrecise Antibodies‘s full profile, request access.

Request a free trial

ImmunoPrecise Antibodies Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 (00 29-Mar-2022 0000000000 0000 Other Healthcare Technology Systems 00000000
000000000 000 06-Apr-2018 0000000000 00.000 Discovery Tools (Healthcare)
000000000 000 30-Jan-2018 0000000000 000.00 Drug Discovery
0000000 29-Dec-2017 000000000 00000 Discovery Tools (Healthcare)
Preclinics 28-Dec-2017 Merger/Acquisition 00.000 Other Services (B2C Non-Financial)
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

ImmunoPrecise Antibodies Subsidiaries (4)

Company Name Industry Location Founded
Preclinics Other Services (B2C Non-Financial) Potsdam, Germany 2007
0-0000000 0000000 Biotechnology Utrecht, Netherlands 0000
000000000 00000000 Drug Discovery Utrecht, Netherlands 0000
000 00000000 Biotechnology Utrecht, Netherlands
To view ImmunoPrecise Antibodies’s complete subsidiaries history, request access »

ImmunoPrecise Antibodies Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 29-Dec-2017 000000000 00000 Completed
  • 0000000000000 0000
To view ImmunoPrecise Antibodies’s complete exits history, request access »